-11.75 (-0.70%) Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharmaceutical Industries has informed that it enclosed the details of issue of duplicate share certificates to the shareholders, as details enclosed.
The above information is a part of company’s filings submitted to BSE.